Patents
Patents for C07C 65 - Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (5,447)
10/2000
10/19/2000CA2305942A1 Composition containing at least one aromatic bicyclic compound and at least one 2-alkyl alcan-1-ol or an ester, and its uses
10/17/2000US6133475 Process for producing 2-hydroxynaphthalene-3,6-dicarboxylic acid
10/17/2000US6133286 Antagonists; antiinflammatory agents for rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, psoriasis and other skin disorders, e.g., eczema, erythema, pruritus and acne; stroke, reperfusion injury, grafting
10/17/2000US6133259 Diagnosis of alzheimer's disease
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059861A1 Selective retinoic acid analogs
10/11/2000EP1043364A1 Toning agent
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042268A1 Dibenzosuberone derivatives and procedures for their preparation
10/05/2000WO2000058258A1 Novel carboxylic acid derivatives and process for producing the same
10/03/2000US6127426 Antiallergic and -inflammatory agents e.g., treating psoriasis, blocked on the c-10 by a nonphenolic arylacyl or a phenylalkylidene group; lipoxygenase inhibitors; antiproliferative agents; low dosage; side effect reduction
10/03/2000US6127415 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/03/2000US6127073 Method for concealing information and document for securely communicating concealed information
09/2000
09/27/2000CN1268130A Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
09/26/2000US6124500 Process for synthesizing benzoic acids
09/20/2000EP0773919B1 Method for preparing 3-carboxy-4-hydroxybenzaldehydes and derivatives thereof
09/19/2000US6121458 Preparation of substituted 3-aryl-5-haloalkyl-pyrazoles having herbicidal activity
09/19/2000US6120949 A temporary markings comprising a colorant, a mutable colorant and an ultraviolet radiation transorber, when irradiating with ultraviolet radiation, and changing the colorant to colorless
09/06/2000EP1032566A2 Method for the preparation of citalopram
09/05/2000US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging
08/2000
08/23/2000EP1028941A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/23/2000EP0637297B1 Compounds having selectivity for retinoid x receptors
08/23/2000CN1264358A Method for producing 3-hydroxy-2-methylbenzoic acid
08/22/2000US6107516 Production of aromatic hydroxycarboxylic acids
08/16/2000EP0859753B1 Process for dicarboxylating dihydric phenols
08/16/2000EP0779883B1 Method for preparing a substituted 4-hydroxybenzaldehyde
08/15/2000US6103762 A biaromatic compounds in which the aromatic nuclei are connected by a propynylene or allenylene divalent radical, useful as human or veterinary medicine or used in cosmetics or keratinization disorders
08/09/2000CN1262266A Process for prepared boronized high-basicity magnesium alkylsalicylate as additive of lubricating oil
08/09/2000CN1262265A Process for preparing boronized middle-basicity calcium alkylsalicylate as additive of lubricating oil
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/02/2000CN1261906A Alkyl, alkenyl and alkynyl chrysamine G derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/01/2000US6096768 Administering a 3, 5, 6-substituted phenyl compound for the treatment of inflammation and autoimmune disorders
07/2000
07/19/2000EP1020478A1 Method of making a substrate comprising a colored composition by using an improved mutable composition and so produced substrate
07/19/2000EP1019356A2 Method for producing 3-hydroxy-2-methylbenzoic acid
07/19/2000CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same
07/18/2000US6090817 Respiratory system disorders; phosphodiesterse inhibitor
07/18/2000US6090810 Side effect reduction
07/18/2000CA2058646C Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid
07/12/2000EP1017680A1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same
06/2000
06/27/2000US6080856 Preparation of arthropodicidal oxadiazines
06/27/2000US6080781 Dissolving tetralone or benzopyranone compounds and a benzaldehyde compound in organic solvent, refluxing with heating under acidic condition and purifying the reactio product; useful for treating hormone dependent disease
06/20/2000CA1341036C Achiral fluorine-containing liquid crystals
06/14/2000EP1008583A1 Process for making 2-alkyl-3-hydroxybenzoic acids
06/14/2000EP0820426B1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION
06/14/2000CN1256264A Process for preparing 2-alkyl-3-hydroxy-benzoic acid
06/07/2000EP1005347A1 Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
06/02/2000WO2000031015A1 Method of modifying components present in cashew nut shell liquid
06/02/2000CA2352331A1 Method of modifying components present in cashew nut shell liquid
05/2000
05/31/2000EP1003709A1 Fungicidal compounds having a fluorovinyloxyphenyl moiety and process for the preparation thereof
05/31/2000EP1003498A1 Di-aryl ethers and their derivatives as anti-cancer agents
05/30/2000CA1341010C Compounds useful in preparing fluorine-containing chiral smectic liquid crystals
05/30/2000CA1341009C Intermediates for preparing 4-oxyquinoline-3-carboxylic acid derivatives
05/24/2000EP1001924A1 The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
05/23/2000US6066761 From an aqueous solution of its metal salt, by reacting with an organic or inorganic acid, heating until a liquid two-phase system is formed, and separating the organic phase from aqueous phase; can be nitrated directly to acifluorfen
05/23/2000US6066439 Instrument for photoerasable marking
05/18/2000WO2000027792A1 Novel compounds and medicinal use thereof
05/18/2000CA2348763A1 Novel compounds and medicinal use thereof
05/17/2000EP1000008A1 Novel thyroid receptor ligands and method
05/17/2000EP0869959B1 1,7-disubstituted perylene-3,4,9,10-tetracarboxylic acids and dianhydrides and diimides of said acids
05/16/2000US6063181 1,7-disubstituted perylene-3,4,9, 10-tetracarboxylic acids, their dianhydrides and diimides of said acids
05/16/2000CA2126752C Benzopyran and related ltb4 antagonists
05/10/2000CN1252789A 3-cyano-2,4,5-trifluoro-benzoyle fluoride and intermediate preparation thereof
05/09/2000US6060223 Plastic article for colored printing and method for printing on a colored plastic article
05/09/2000US6060200 Photo-erasable data processing forms and methods
05/02/2000US6057345 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
04/2000
04/27/2000WO2000023526A1 Toning agent
04/27/2000WO2000023413A1 Method for drying phenoxymethylbenzoic acids
04/27/2000DE19848200A1 Drying phenoxymethylbenzoic acid derivatives comprises heating at a temperature above their melting point and under the same temperature and pressure as during synthesis
04/27/2000CA2314118A1 Toning agent
04/26/2000CN1051759C Process for preparing arylethanolamine
04/25/2000US6054256 Colorimetric analysis; detecting dosage radiation
04/18/2000US6051601 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists
04/18/2000US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
04/12/2000EP0991636A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
04/12/2000CN1051298C Substituted cyclohexanolester, its use for treatment of disease and pharmaceutical agent
04/11/2000US6048986 Dehydration of difluoropyromellitic acid to form difluoropyromellitic dianhydride
04/11/2000CA1340959C Intermediates for pyrazole derivative herbicides
04/04/2000US6046220 Propynyl or dienyl biaromatic compounds
04/04/2000US6046212 Antiallergic agents
03/2000
03/30/2000WO2000017147A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity
03/30/2000CA2344310A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity
03/29/2000EP0989105A1 Process for producing aromatic compounds via treatment with supercritical water
03/28/2000US6043279 Compounds used for in vivo modulation of lipid metabolism, skin-related processes, malignant cell development, premalignant lesions, programmed cell death
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/22/2000EP0986533A1 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis
03/22/2000CN1248239A Method for isolating 3-[2-chloro-4-(trifluoromethyl) -phenoxyl]-benzoic acid
03/21/2000US6040478 Contacting a dihydric phenol with carbon dioxide in the presence of an alkali metal carbonate and alkali metal formate at a temperature above the melting point of the formate (solvent); efficiency; low pressure; kinetics
03/21/2000US6040111 Aromatic hydroxycarboxylic acid resins and their use
03/16/2000WO1999043636A3 Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
03/14/2000US6037488 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
03/08/2000EP0983992A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983991A2 Compounds having selectivity for retinoid x receptors
03/07/2000US6033465 Colorants and colorant modifiers
03/07/2000CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
02/2000
02/23/2000EP0980350A2 Hydroxynaphthoic acids and derivatives
02/22/2000US6028052 Treating NIDDM with RXR agonists
02/17/2000WO2000007972A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
02/17/2000CA2339194A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
02/16/2000CN1049438C Organometallic fluorenyl compounds and method for polymerising olefine by using said compound
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 55